Drug-target interaction prediction by random walk on the heterogeneous network.
暂无分享,去创建一个
[1] Yoshihiro Yamanishi,et al. Supervised prediction of drug–target interactions using bipartite local models , 2009, Bioinform..
[2] J. Lehár,et al. Multi-target therapeutics: when the whole is greater than the sum of the parts. , 2007, Drug discovery today.
[3] Luhua Lai,et al. Prediction of potential drug targets based on simple sequence properties , 2007, BMC Bioinformatics.
[4] P. Robinson,et al. Walking the interactome for prioritization of candidate disease genes. , 2008, American journal of human genetics.
[5] Thomas Lengauer,et al. A fast flexible docking method using an incremental construction algorithm. , 1996, Journal of molecular biology.
[6] S. Frantz. Drug discovery: Playing dirty , 2005, Nature.
[7] Yong Wang,et al. Computationally Probing Drug-Protein Interactions Via Support Vector Machine , 2010 .
[8] Xing Chen,et al. A novel candidate disease genes prioritization method based on module partition and rank fusion. , 2010, Omics : a journal of integrative biology.
[9] M S Waterman,et al. Identification of common molecular subsequences. , 1981, Journal of molecular biology.
[10] Jagdish Chandra Patra,et al. Genome-wide inferring gene-phenotype relationship by walking on the heterogeneous network , 2010, Bioinform..
[11] Elena Marchiori,et al. Gaussian interaction profile kernels for predicting drug-target interaction , 2011, Bioinform..
[12] David S. Wishart,et al. DrugBank: a knowledgebase for drugs, drug actions and drug targets , 2007, Nucleic Acids Res..
[13] Stuart L. Schreiber,et al. Dissecting glucose signalling with diversity-oriented synthesis and small-molecule microarrays , 2002, Nature.
[14] P. Bork,et al. Drug Target Identification Using Side-Effect Similarity , 2008, Science.
[15] Antje Chang,et al. New Developments , 2003 .
[16] L. Lai,et al. Finding multiple target optimal intervention in disease-related molecular network , 2008, Molecular systems biology.
[17] Darren R. Flower,et al. On the Properties of Bit String-Based Measures of Chemical Similarity , 1998, J. Chem. Inf. Comput. Sci..
[18] S. Haggarty,et al. Multidimensional chemical genetic analysis of diversity-oriented synthesis-derived deacetylase inhibitors using cell-based assays. , 2003, Chemistry & biology.
[19] J. Drews. Drug discovery: a historical perspective. , 2000, Science.
[20] Michael J. Keiser,et al. Predicting new molecular targets for known drugs , 2009, Nature.
[21] Weiming Yu,et al. Predicting drug‐target interactions based on an improved semi‐supervised learning approach , 2011 .
[22] Yoshihiro Yamanishi,et al. Drug-target interaction prediction from chemical, genomic and pharmacological data in an integrated framework , 2010, Bioinform..
[23] Yoshihiro Yamanishi,et al. Prediction of drug–target interaction networks from the integration of chemical and genomic spaces , 2008, ISMB.
[24] Kiyoko F. Aoki-Kinoshita,et al. From genomics to chemical genomics: new developments in KEGG , 2005, Nucleic Acids Res..
[25] Jürgen Bajorath,et al. Combinatorial Preferences Affect Molecular Similarity/Diversity Calculations Using Binary Fingerprints and Tanimoto Coefficients , 2000, J. Chem. Inf. Comput. Sci..
[26] J. Gies,et al. Drugs and their molecular targets: an updated overview , 2008, Fundamental & clinical pharmacology.
[27] M. Kanehisa,et al. Development of a chemical structure comparison method for integrated analysis of chemical and genomic information in the metabolic pathways. , 2003, Journal of the American Chemical Society.
[28] Xiaobo Zhou,et al. Semi-supervised drug-protein interaction prediction from heterogeneous biological spaces , 2010, BMC Systems Biology.
[29] Robert B. Russell,et al. SuperTarget and Matador: resources for exploring drug-target relationships , 2007, Nucleic Acids Res..
[30] John P. Overington,et al. How many drug targets are there? , 2006, Nature Reviews Drug Discovery.